Does artificial intelligence redefine nuclear-to-cytoplasmic ratio threshold for diagnosing high-grade urothelial carcinoma?

IF 2.6 3区 医学 Q3 ONCOLOGY
Wei-Lei Yang PhD, Barbara A. Crothers DO, Tien-Jen Liu MD, Shih-Wen Hsu MS, Cheng-Hung Yeh MS, Yi-Siou Liu MS, Guowei Shao MS, Ming-Yu Lin PhD, Tang-Yi Tsao MD, Min-Che Tung MD, Pei-Yi Chu MD, Jen-Fan Hang MD, FIAC
{"title":"Does artificial intelligence redefine nuclear-to-cytoplasmic ratio threshold for diagnosing high-grade urothelial carcinoma?","authors":"Wei-Lei Yang PhD,&nbsp;Barbara A. Crothers DO,&nbsp;Tien-Jen Liu MD,&nbsp;Shih-Wen Hsu MS,&nbsp;Cheng-Hung Yeh MS,&nbsp;Yi-Siou Liu MS,&nbsp;Guowei Shao MS,&nbsp;Ming-Yu Lin PhD,&nbsp;Tang-Yi Tsao MD,&nbsp;Min-Che Tung MD,&nbsp;Pei-Yi Chu MD,&nbsp;Jen-Fan Hang MD, FIAC","doi":"10.1002/cncy.70017","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The Paris System (TPS) introduced standardized nuclear-to-cytoplasmic (N/C) ratio thresholds for urine cytology to improve high-grade urothelial carcinoma (HGUC) detection, but these criteria remain subjective. This study used AIxURO, an artificial intelligence-based model, to measure N/C ratio and nuclear area to identify abnormal cells in whole slide images (WSIs).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A total of 106 urine cytology slides from 46 lower urinary tract (LUT) and 60 upper urinary tract (UUT) cancer cases, diagnosed as atypical urothelial cell (15.1%), suspicious for high-grade urothelial carcinoma (SHGUC) (23.6%), and HGUC (61.3%), with biopsy-confirmed HGUC or carcinoma in situ (CIS), were digitized and analyzed by AIxURO. The model quantified suspicious and atypical cells, N/C ratios, and nuclear areas, with statistical differences assessed using Kruskal–Wallis tests.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>AIxURO identified fewer suspicious cells than atypical cells (20.5 vs. 242.0, <i>p</i> &lt; .001). Suspicious cells had higher N/C ratios (0.66 vs. 0.58, <i>p</i> &lt; .001) and larger nuclear areas (102.3 vs. 85.7 µm<sup>2</sup>, <i>p</i> &lt; .001). Although N/C ratios did not differ significantly between UUT and LUT cases, nuclear areas varied among abnormal cells (CIS: 101.5 µm<sup>2</sup>; HGUC: 83.5 µm<sup>2</sup>). In HGUC cytology cases, the CIS category had larger nuclear areas than HGUC for both suspicious (116.3 vs. 100.4 µm<sup>2</sup>) and atypical cells (101.5 vs. 82.2 µm<sup>2</sup>).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>AIxURO provides objective quantification of N/C ratios and nuclear areas, refining TPS criteria for distinguishing suspicious from atypical cells. A lower N/C ratio cutoff (0.66) for SHGUC/HGUC may be more appropriate than the TPS threshold (&gt;0.7). Findings support using consistent N/C ratio criteria across UUT and LUT cases.</p>\n </section>\n </div>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":"133 5","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncy.70017","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Cytopathology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncy.70017","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The Paris System (TPS) introduced standardized nuclear-to-cytoplasmic (N/C) ratio thresholds for urine cytology to improve high-grade urothelial carcinoma (HGUC) detection, but these criteria remain subjective. This study used AIxURO, an artificial intelligence-based model, to measure N/C ratio and nuclear area to identify abnormal cells in whole slide images (WSIs).

Methods

A total of 106 urine cytology slides from 46 lower urinary tract (LUT) and 60 upper urinary tract (UUT) cancer cases, diagnosed as atypical urothelial cell (15.1%), suspicious for high-grade urothelial carcinoma (SHGUC) (23.6%), and HGUC (61.3%), with biopsy-confirmed HGUC or carcinoma in situ (CIS), were digitized and analyzed by AIxURO. The model quantified suspicious and atypical cells, N/C ratios, and nuclear areas, with statistical differences assessed using Kruskal–Wallis tests.

Results

AIxURO identified fewer suspicious cells than atypical cells (20.5 vs. 242.0, p < .001). Suspicious cells had higher N/C ratios (0.66 vs. 0.58, p < .001) and larger nuclear areas (102.3 vs. 85.7 µm2, p < .001). Although N/C ratios did not differ significantly between UUT and LUT cases, nuclear areas varied among abnormal cells (CIS: 101.5 µm2; HGUC: 83.5 µm2). In HGUC cytology cases, the CIS category had larger nuclear areas than HGUC for both suspicious (116.3 vs. 100.4 µm2) and atypical cells (101.5 vs. 82.2 µm2).

Conclusions

AIxURO provides objective quantification of N/C ratios and nuclear areas, refining TPS criteria for distinguishing suspicious from atypical cells. A lower N/C ratio cutoff (0.66) for SHGUC/HGUC may be more appropriate than the TPS threshold (>0.7). Findings support using consistent N/C ratio criteria across UUT and LUT cases.

Abstract Image

人工智能是否重新定义了诊断高级别尿路上皮癌的核质比阈值?
巴黎系统(TPS)引入了标准化的尿细胞学核/细胞质(N/C)比值阈值,以提高高级别尿路上皮癌(HGUC)的检测,但这些标准仍然是主观的。本研究采用基于人工智能的AIxURO模型,测量N/C比率和核面积,以识别全片图像(WSIs)中的异常细胞。方法对诊断为非典型尿路上皮细胞(15.1%)、怀疑为高级别尿路上皮癌(SHGUC)(23.6%)、怀疑为HGUC(61.3%)、活检证实为HGUC或原位癌(CIS)的46例下尿路癌(LUT)和60例上尿路癌(UUT)患者的106张尿细胞学切片进行数字化分析。该模型量化了可疑和非典型细胞、N/C比率和核面积,并使用Kruskal-Wallis试验评估了统计差异。结果AIxURO鉴定出的可疑细胞少于非典型细胞(20.5 vs. 242.0, p <;措施)。可疑细胞的N/C比值较高(0.66 vs. 0.58, p <;.001)和更大的核区域(102.3 vs. 85.7µm2, p <;措施)。尽管在UUT和LUT病例中N/C比率没有显著差异,但异常细胞的核面积存在差异(CIS: 101.5µm2;HGUC: 83.5µm2)。在HGUC细胞学病例中,CIS类别的可疑细胞(116.3 vs 100.4µm2)和非典型细胞(101.5 vs 82.2µm2)的核面积都比HGUC大。结论AIxURO提供了客观定量的N/C比和核面积,完善了TPS标准,用于区分可疑细胞和非典型细胞。SHGUC/HGUC较低的N/C比值临界值(0.66)可能比TPS阈值(>0.7)更合适。研究结果支持在UUT和LUT病例中使用一致的N/C比率标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Cytopathology
Cancer Cytopathology 医学-病理学
CiteScore
7.00
自引率
17.60%
发文量
130
审稿时长
1 months
期刊介绍: Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信